| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.39 | 0.03 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |